Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: A phase I/IIa clinical trial

European Spine Journal

Volumn 21, Issue 12, 2012, Pages 2580-2587

  Takahashi, Hiroshi ^a   Yamazaki, Masashi ^a   Okawa, Akihiko ^a   Sakuma, Tsuyoshi ^a   Kato, Kei ^a   Hashimoto, Mitsuhiro ^a   Hayashi, Koichi ^a   Furuya, Takeo ^a   Fujiyoshi, Takayuki ^a   Kawabe, Junko ^a   Yamauchi, Tomonori ^a   Mannoji, Chikato ^a   Miyashita, Tomohiro ^a   Kadota, Ryo ^a   Hashimoto, Masayuki ^a   Ito, Yasuo ^b   Takahashi, Kazuhisa ^a   Koda, Masao ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Kobe Red Cross Hospital   (Japan)

Author keywords

Clinical trial; G CSF; Neuroprotective therapy; Spinal cord injury

Indexed keywords

ANTIBIOTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE SODIUM SUCCINATE; NEUROPROTECTIVE AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AMERICAN SPINAL CORD INJURY ASSOCIATION SCORE; AMERICAN SPINAL INJURY ASSOCIATION IMPAIRMENT SCALE; ARTICLE; CERVICAL SPINE INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; FALLING; FEASIBILITY STUDY; FEMALE; HUMAN; LEUKOCYTE COUNT; LIVER DISEASE; LIVER DYSFUNCTION; MALE; MOTOR PERFORMANCE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROPROTECTION; OPEN STUDY; PARALYSIS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; SENSORY SYSTEM; SIDE EFFECT; SPINAL CORD INJURY; SPORT INJURY; STOMACH ULCER; THORACIC SPINE; TOUCH; TREATMENT DURATION; URINARY TRACT INFECTION;

ADULT; AGED; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; RECOVERY OF FUNCTION; SPINAL CORD INJURIES;

EID: 84875730225     PISSN: 09406719     EISSN: 14320932     Source Type: Journal    
DOI: 10.1007/s00586-012-2213-3     Document Type: Article

References (36)

1. Anderlini P, Przepiorka D, Seong D et al (1996) Clinical toxicity and laboratory effects of granulocyte colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors and analysis of charge for procedures. Transfusion 36:590-595 (Pubitemid 26256425)
2. Azuma J, Awata S, Sawamura A et al (1989) Phase 1 study of KRN8601 (rhG-CSF) in normal healthy volunteers: safety and pharmacokinetics in consecutive intravenous infusion. Rinsho Iyaku J Clin Ther Med 5:1605-1622 (in Japanese)
3. Becker PS, Wagle M, Matous S et al (1997) Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF) occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant 3:45-49 (Pubitemid 127531528)
4. Bensinger WI, Clift TA, Anasetti C et al (1996) Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor. Stem Cells 14:90-105 (Pubitemid 26041424)
5. Bracken MB, Shepard MJ, Collins WF et al (1990) A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury: results of the second national acute spinal cord injury study. N Engl J Med 322:1405-1411 (Pubitemid 20152525)
6. Bracken MB, Shepard MF, Holford TR et al (1997) Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury: results of the third national acute spinal injury randomized controlled trial. JAMA 277:1597-1604 (Pubitemid 27231191)
7. Engelmann MG, Theiss HD, Hennig-Theiss C et al (2006) Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J Am Coll Cardiol 48:1712-1721 (Pubitemid 44528196)
8. Falzetti F, Aversa F, Minelli O et al (1999) Spontaneous rupture of spleen during peripheral blood stem cell mobilization in a healthy donor. Lancet 353:555 (Pubitemid 29078428)
9. Fleming JC, Norenberg MD, Ramsay DA et al (2006) The cellular inflammatory response in human spinal cords after injury. Brain 129:3249-3269 (Pubitemid 44871440)
10. Gibson CL, Jones NC, Prior MJ et al (2005) G-CSF suppresses edema formation and reduces interleukin-1β expression after cerebral ischemia in mice. J Cereb Blood Flow Metab 25:431-439
11. Henriques A, Pitzer C, Dittgen T et al (2011) CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit. Mol Ther 19:284-292
12. Ince H, Petzsch M, Kleine HD et al (2005) Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial. Circulation 112:173-180 (Pubitemid 43113441)
13. Ito Y, Sugimoto Y, Tomioka M et al (2009) Does high dose methylprednisolone sodium succinate really improve neurological status in patient with acute cervical cord injury? A prospective study about neurological recovery and early complications. Spine 34:2121-2124
14. Iwasaki H, Kawamoto A, Ishikawa M et al (2006) Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 113:1311-1325 (Pubitemid 43739453)
15. Kawabe J, Koda M, Hashimoto M et al (2011) Granulocyte colony-stimulating factor (G-CSF) exerts neuroprotective effects via promoting angiogenesis after spinal cord injury in rats. J Neurosurg Spine 15:414-421
16. Kawada H, Takizawa S, Takanashi T et al (2006) Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation 113:701-710
17. Koda M, Nishio Y, Kamada T et al (2007) Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice. Brain Res 1149:223-231 (Pubitemid 46659901)
18. Komine-Kobayashi M, Zhang N, Liu M et al (2006) Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J Cereb Blood Flow Metab 26:402-413
19. Matsumoto T, Tamaki T, Kawakami M et al (2001) Early complications of high-dose methyl-prednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury. Spine 26:426-430 (Pubitemid 32184858)
20. Maynard FM Jr, Bracken MB, Creasey G et al (1997) International Standards for Neurological and Functional Classification of Spinal Cord Injury. American Spinal Injury Association. Spinal Cord 35:266-274 (Pubitemid 27235039)
21. Murata M, Harada M, Kato S et al (1999) Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donors. Bone Marrow Transplant 24:1065-1071
22. Nefussy B, Artamonov I, Deutsch V et al (2010) Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: a pilot study. Amyotroph Lateral Scler 11:187-193
23. Nicola NA, Metcalf D, Matsumoto M et al (1983) Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. J Biol Chem 258:9017-9023 (Pubitemid 13026729)
24. Nishio Y, Koda M, Kamada T et al (2007) Granulocyte colony-stimulating factor attenuates neuronal death and promotes functional recovery after spinal cord injury in mice. J Neuropathol Exp Neurol 66:724-731 (Pubitemid 47344251)
25. Pannu R, Barbosa E, Singh AK et al (2005) Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats. J Neurosci Res 79:340-350 (Pubitemid 40278348)
26. Pitzer C, Kruger C, Plaas C et al (2008) Granulocyte colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis. Brain 31:335-347
27. Ripa RS, Jorgensen E, Wang Y et al (2006) Stem cell mobilization induced by subcutaneous granulocyte colony-stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 113:1983-1992
28. Roberts AW (2005) G-CSF: a key regulator of neutrophil production, but that's not all! Growth Factors 23:33-41 (Pubitemid 41656869)
29. Sakuma T, Yamazaki M, Okawa A et al (2011) Neuroprotective therapy using granulocyte-colony stimulating factor for patients with worsening symptoms of compression myelopathy, part 1: a phase I and IIa clinical trial. Eur Spine J [Sep 21, Epub ahead of print]
30. Schäbitz WR, Kollmar R, Schwaninger M et al (2003) Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 34:745-751 (Pubitemid 36307405)
31. Schneider A, Kuhn HG, Schäbitz WR (2005) A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system. Cell Cycle 4:1753-1757 (Pubitemid 41827320)
32. Shyu WC, Lin SZ, Lee CC et al (2006) Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. CMAJ 174:927-933
33. Takano H, Hasegawa H, Kuwabara Y et al (2007) Feasibility and safety of granulocyte colony-stimulating factor treatment in patients with acute myocardial infarction. Int J Cardiol 122:41-47 (Pubitemid 47503345)
34. Valgimigli M, Rigolin GM, Cittanti C et al (2005) Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile. Eur Heart J 26:1838-1845 (Pubitemid 41253295)
35. Zhang Y, Wang L, Fu Y et al (2009) Preliminary investigation of effect of granulocyte colony stimulating factor on amyotrophic lateral sclerosis. Amyotroph Later Scler 10:430-431
36. Zohlnhofer D, Ott I, Mehilli J et al (2006) REVIVAL-2 Investigators. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 295:1003-1010